Retatrutide is an investigational multi-receptor peptide agonist that combines activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is a next-generation metabolic therapy designed to leverage the synergistic effects of these three hormonal pathways to improve energy expenditure, insulin sensitivity, and appetite control. Mechanistically, GLP-1 and GIP agonism enhances glucose-dependent insulin secretion, delays gastric emptying, and reduces food intake, while glucagon receptor activation increases lipolysis and energy expenditure. This triple-action…
Semaglutide (2mg/vial) + Bacteriostatic Water (0.9%) 2 ml is a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 (GLP-1) to regulate blood sugar levels, appetite, and metabolism. Originally developed for type 2 diabetes management, it is widely used for weight loss and appetite suppression due to its ability to reduce hunger, slow gastric emptying, and enhance insulin sensitivity. This compound lowers blood sugar by increasing insulin secretion and reducing glucagon…
